Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
General Motors Financial $400 million senior notes offering
The investment-grade notes are due 2026
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Advent International $2.25 billion Maxar Technologies acquisition financing
We advised the lenders on the facilities
Anglo American $900 million notes offering
The 5.500% senior notes are due 2033
Meta Platforms $8.5 billion senior notes offering
We advised Meta on the investment-grade debt offering
Invacare chapter 11 plan confirmed
We advised the prepetition term loan agent and escrow agent on the transaction